Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
N. Hamaguchi, H. Hamada, S. Miyoshi, R. Ito, J. Higaki (Toon, Japan). The inhibitory effect of peroxisome proliferator activated receptor-γ ligands on malignant pleural mesothelioma cell growth. Eur Respir J 2009; 34: Suppl. 53, 1794

Member's Comments

No comment yet.

Related content which might interest you: The inhibitory effect of peroxisome proliferator-activated receptor-γ ligands on malignant pleural mesothelioma cell growth Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Peroxisome proliferator activated receptor gamma (PPARγ) agonist rosiglitizone inhibits upregulation of mucin gene expression in two airway epithelial cell lines Source: Eur Respir J 2005; 26: Suppl. 49, 97s Year: 2005 Activation of airway epithelial cell inhibited by peroxisome proliferator-activated receptor γ Source: Eur Respir J 2006; 28: Suppl. 50, 229s Year: 2006 The relationship of peroxisome proliferator activated receptor γ ligands and IL-6 in sepsis of rats Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009 The effect of peroxisome proliferator-activated receptor-? ligands on in vitro and in vivo models of COPD Source: Eur Respir J 2014; 43: 409-420 Year: 2013 Role of peroxisome proliferator activated receptor γ in COPD Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Role of exogenous ligands for the peroxisome proliferator-activated receptor-β/δ in the development of bleomycin-induced lung injury Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 PPAR-γ agonists as therapy for diseases involving airway neutrophilia Source: Eur Respir J 2004; 24: 18-23 Year: 2004 Impacts of peroxisome proliferator-activated receptor gamma activation on cigarette smoke-induced exacerbated response to bacteria Source: Eur Respir J 2015; 45: 191-200 Year: 2015 Forced chemokine ligand 2 overexpression renders melanoma cells capable of inducing experimental malignant pleural effusion Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 The role of peroxisome proliferator-activated receptor γ in pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Down-regulation of retinoid receptors in malignant mesotheliomas Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001 Role of NF-?B and PPAR-? in lung inflammation induced by monocyte-derived microparticles Source: Eur Respir J 2011; 37: 1494-1502 Year: 2011 The interaction of glucocorticoid and peroxisome proliferator-activated receptor γ agonist in asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 226s Year: 2006 Relationship between peroxisome proliferator-activated receptor α and neutrophils in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 452s Year: 2004 Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Source: Eur Respir J 2008; 32: 924-930 Year: 2008 The perxisome proliferator-activated receptor gamma agonist, rosiglitazone, inhibits IL-8 synthesis by airway epithelial cells stimulated with monocyte-derived microparticles Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD Source: Eur Respir J 2007; 30: 245-252 Year: 2007 Transcriptional regulation of the human cystic fibrosis transmembrane conductance regulator gene promoter by peroxisome proliferator-activated receptor γ Source: Eur Respir J 2007; 30: Suppl. 51, 38s Year: 2007 Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006